What is the oral (PO) loading dose of amiodarone?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Oral Loading Dose of Amiodarone

The oral loading dose of amiodarone is 800 to 1,600 mg per day in divided doses until a total of 10 g has been given for ventricular arrhythmias, or 600 to 800 mg per day in divided doses until a total of 10 g has been given for atrial fibrillation. 1

Dosing Regimen by Indication

Ventricular Arrhythmias

  • Initial loading: 800-1,600 mg/day in divided doses
  • Continue until total of 10 g has been administered (approximately 1-2 weeks)
  • Maintenance: 200-400 mg/day 1

Atrial Fibrillation

  • Initial loading: 600-800 mg/day in divided doses
  • Continue until total of 10 g has been administered
  • Higher initial dosages or IV dosing may be used in unstable inpatients
  • Maintenance: 200 mg/day 1

Transition from IV to Oral Therapy

When converting from intravenous to oral amiodarone, the oral loading dose should be adjusted based on the duration of previous IV therapy:

  • IV therapy <1 week: 800-1,600 mg oral amiodarone daily
  • IV therapy 1-3 weeks: 600-800 mg oral amiodarone daily
  • IV therapy >3 weeks: 400 mg oral amiodarone daily 1, 2

Administration Considerations

  • Oral doses should be given in divided doses (typically twice daily during loading)
  • Loading doses should be administered with food to minimize gastrointestinal side effects
  • Potassium and magnesium levels should be maintained >4.0 mEq/L before and during therapy 2
  • Tablets should not be cut; dose adjustments should be made by changing the prescribed tablet strength 2

Monitoring During Loading Phase

During the loading phase, patients should be monitored for:

  • QT interval prolongation
  • Bradycardia
  • Gastrointestinal side effects (constipation, nausea)
  • Neurological effects (ataxia, tremor, paresthesias) 1, 2

Important Considerations and Pitfalls

  • Side effects are common (occurring in up to 93% of patients) and often dose-related 3, 4
  • Higher loading doses (>1,800 mg/day) have been used in unstable patients with incessant ventricular tachyarrhythmias, but should be reserved for these critical cases 5
  • Amiodarone has a narrow therapeutic-toxic range; close monitoring is essential 3
  • The long half-life of amiodarone (14-58 days) means that steady state may not be achieved for weeks to months 6
  • Drug interactions are significant, particularly with warfarin, digoxin, and statins; dose adjustments of these medications may be necessary 2

Clinical Efficacy

Amiodarone has shown efficacy rates of 76-83% for controlling refractory tachyarrhythmias 7. The electrophysiologic effects begin within the first day of high-dose loading, with progressive increases in ventricular tachycardia cycle length and right ventricular effective refractory period 5.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Amiodarone Use in Patients with End-Stage Renal Disease (ESRD)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Toxic and therapeutic effects of amiodarone in the treatment of cardiac arrhythmias.

Journal of the American College of Cardiology, 1983

Research

High dose oral amiodarone loading: electrophysiologic effects and clinical tolerance.

Journal of the American College of Cardiology, 1992

Research

Amiodarone: a unique antiarrhythmic agent.

Clinical pharmacy, 1983

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.